Perrigo (PRGO) Total Non-Current Liabilities (2013 - 2026)

Perrigo's (PRGO) quarterly Total Non-Current Liabilities came in at $4.5 billion in Q1 2026, up 3.82% year-on-year from $4.3 billion in Q1 2025, and down 2.18% on a QoQ basis from $4.6 billion in Q4 2025.

Perrigo (PRGO) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Total Non-Current Liabilities data on file, last reported at $4.5 billion in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 3.82% year-over-year to $4.5 billion in Q1 2026; TTM through Mar 2026 was $4.5 billion, a 3.82% increase from a year earlier, with the FY2025 full-year figure at $4.6 billion, up 7.07% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $4.5 billion, down from $4.6 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for PRGO reached as high as $5.2 billion in Q3 2024 and fell as low as $4.3 billion in Q4 2024.
  • Historically, Total Non-Current Liabilities has averaged $4.7 billion across 5 years, with a median of $4.5 billion in 2025.
  • Across the five-year window, Total Non-Current Liabilities jumped 37.32% in 2022 and dropped 13.74% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $5.1 billion in 2022, then declined by 11.99% to $4.5 billion in 2023, then decreased by 3.83% to $4.3 billion in 2024, then rose by 7.07% to $4.6 billion in 2025, then dropped by 2.18% to $4.5 billion in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $4.5 billion in Q1 2026, $4.6 billion in Q4 2025, and $4.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn 4.49 Bn

Historic Data

Download Data
DateValue
Mar 28, 2026 4.49 Bn
Dec 31, 2025 4.59 Bn
Sep 27, 2025 4.49 Bn
Jun 28, 2025 4.50 Bn
Mar 29, 2025 4.32 Bn
Dec 31, 2024 4.28 Bn
Sep 28, 2024 5.19 Bn
Jun 29, 2024 4.36 Bn
Mar 30, 2024 4.40 Bn
Dec 31, 2023 4.45 Bn
Sep 30, 2023 5.01 Bn
Jul 1, 2023 5.06 Bn
Apr 1, 2023 5.03 Bn
Dec 31, 2022 5.06 Bn
Oct 1, 2022 5.06 Bn
Jul 2, 2022 5.06 Bn
Apr 2, 2022 4.30 Bn
Dec 31, 2021 3.69 Bn
Oct 2, 2021 3.73 Bn
Jul 3, 2021 3.73 Bn